1. NKF-K/DOKI clinical practice guidelines for chronic kidney diseases: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (suppl. 1): S17–S31.
2. NKF-KDOQI Guidelines on Diabetes and CKD. Am J Kid Dis 2007; 2 suppl. 2: S12–S143.
3. Patel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
4. Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
5. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dialys 2004; 17: 365–70.
6. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab 2000; 26 (suppl. 4): 73–85.
7. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. МИА, 2009.